Ordered by number of citations. From Science Watch:
1 P.M. Ridker, et al., "C-reactive protein levels and outcomes after statin therapy," New Engl. J. Med., 352(1): 20-8, 6 January 2005. 124Technorati Tags: science watch, new england journal of medicine, research, 2005
2 G.H. Bardy, et al., "Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure," New Engl. J. Med., 352(3): 225-37, 20 January 2005. 107
3 S.D. Solomon, et al., "Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention," New Engl. J. Med., 352(11): 1071-80, 17 March 2005. 97
4 R.S. Bresalier, et al., "Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial," New Engl. J. Med., 352(11): 1092-1102, 17 March 2005. 93
5 J.C. Barrett, et al., "Haploview: analysis and visualization of LD and haplotype maps," Bioinformatics, 21(2): 263-5, 15 January 2005. 90
6 S.E. Nissen, et al., "Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease," New Engl. J. Med., 352(1): 29-38, 6 January 2005. 82
7 D.A. Hinds, et al., "Whole-genome patterns of common DNA variation in three human populations," Science, 307(5712): 1072-9, 18 February 2005. 74
8 L.P. Lim, et al., "Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs," Nature, 433(7027): 769-73, 17 February 2005. 73
9 E.R. Miller, et al., "Meta-analysis: High-dosage vitamin E supplementation may increase all-cause mortality," Ann. Intern. Med., 142(1): 37-46, 4 January 2005. 73
10 A. Howell, et al., "Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years adjuvant treatment for breast cancer," Lancet, 365(9453): 60-2, 1 January 2005...
No comments:
Post a Comment